Journey Lite of Cincinnati

Journey Lite of Cincinnati operates as an MBSAQIP-Accredited Bariatric Surgery Outpatient Center of Excellence in Cincinnati, Ohio, under the medical direction of Dr. Trace Curry, MD. The clinic holds multiple national quality designations including Anthem Blue Distinction Plus, United Health Optum Bariatric Center of Excellence, and Aetna Institute of Quality recognition, reflecting adherence to evidence-based protocols for obesity treatment and surgical weight management. Journey Lite provides both surgical bariatric procedures and non-surgical medical weight management programs, positioning itself as a comprehensive resource for patients across the weight loss treatment spectrum in the Greater Cincinnati region.

The medical weight management division offers three FDA-approved GLP-1 receptor agonist peptides: semaglutide, tirzepatide, and liraglutide. Semaglutide therapy follows weekly subcutaneous injection protocols with dose titration based on patient tolerance and weight loss response. Tirzepatide, a dual GIP/GLP-1 receptor agonist, is prescribed for patients who may benefit from the additional incretin pathway modulation. Liraglutide serves as an alternative daily injection option for patients requiring more frequent dosing intervals or those transitioning from other weight management approaches. Each peptide protocol includes baseline metabolic assessment, ongoing monitoring of glycemic parameters when indicated, and adjustment of dosing schedules based on clinical response and side effect profiles.

Dr. Trace Curry leads the clinical team with a focus on individualized treatment planning that considers patient medical history, weight loss goals, comorbid conditions, and insurance coverage parameters. The practice employs registered dietitians who work directly with peptide therapy patients to optimize nutritional intake during active weight loss phases, addressing common challenges such as protein adequacy, micronutrient supplementation, and meal timing strategies that complement GLP-1 medication effects. Nursing staff coordinate prior authorizations, provide injection technique training, and manage follow-up scheduling to ensure patients maintain consistent contact with the care team throughout treatment duration.

Patients begin with an in-person consultation at the Cincinnati office where medical history review, physical examination, and discussion of treatment options occur. For those pursuing peptide therapy, the initial visit includes education on medication administration, expected timeline for weight loss, management of gastrointestinal side effects, and criteria for dose escalation. Follow-up visits are scheduled at intervals determined by the specific peptide protocol and individual patient needs, with weight tracking, blood pressure monitoring, and assessment of treatment tolerance conducted at each appointment. The dietitian provides ongoing nutritional counseling to address changing caloric needs and eating patterns as weight decreases.

Journey Lite's multiple Center of Excellence designations require the clinic to maintain specific outcome reporting, patient safety protocols, and multidisciplinary care coordination standards. This infrastructure benefits medical weight management patients through systematic tracking of progress metrics, structured communication between providers, and access to support resources typically associated with bariatric surgical programs. The Cincinnati location serves patients throughout Southwest Ohio, with insurance verification services available to determine coverage for GLP-1 peptide therapies under medical weight management benefits, which vary significantly by payer and plan type.